Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM087290-003
Application #
3615985
Study Section
Project Start
1988-09-30
Project End
Budget Start
1990-07-02
Budget End
1991-09-29
Support Year
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Albertini, M R; Hank, J A; Schiller, J H et al. (1997) Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients. Clin Cancer Res 3:1277-88
Albertini, M R; Gan, J; Jaeger, P et al. (1996) Systemic interleukin-2 modulates the anti-idiotypic response to chimeric anti-GD2 antibody in patients with melanoma. J Immunother Emphasis Tumor Immunol 19:278-95
Mahvi, D M; Madsen, J A; Witt, P L et al. (1995) Interferon alpha enhances expression of TAG-72 and carcinoembryonic antigen in patients with primary colorectal cancer. Cancer Immunol Immunother 40:311-4